September 29, 2020
New center established by the School of Pharmacy, in collaboration with the University of Michigan, will increase access to safe and effective generic drugs through collaborative research, training, and exchange.
August 14, 2015
Collaborative study helps validate effectiveness of FDA’s bioequivalence standard, showing no significant differences between major brand name and generic medication used to treat patients with epilepsy.
August 6, 2015
Testimony examined the impact of FDA-supported research in generic drugs and advocated for continued funding through renewal of the Generic Drug User Fee Amendments of 2012 (GDUFA).
February 24, 2015
Interdisciplinary group will research the effectiveness of brand versus generic iron medications used to treat anemia in kidney disease patients
January 12, 2015
Grants will support the development of quantitative pharmacometric models to advance the evaluation of generic drugs.
July 3, 2013
Drs. Hoag and Polli examine current regulatory science initiatives aimed at generic drugs and discuss ways in which existing initiatives can be improved.
June 4, 2013
New developments in pharmaceutical manufacturing and topical drug bioequivalence and bioavailability addressed in two day-long workshops.
November 15, 2012
Leslie Benet, PhD, professor and former chair of the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco (UCSF), delivers keynote address.
October 15, 2012
Professor emeritus is internationally recognized for his research and mentoring in pharmaceutics, drug process engineering, and in dietary supplements.
January 4, 2012
FDA to rule on complexities of copycat vaccines, blood therapies, toxin products, and other biologic therapies that are similar, but not exactly the same, as brand products.
October 4, 2010
$1.1 million, two-year contract will study the “switchability” of anti-epileptic drugs and address safety and effectiveness concerns
